<DOC>
	<DOCNO>NCT01150058</DOCNO>
	<brief_summary>RATIONALE : Studying cell sample patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer PURPOSE : This research study study drug biomarkers cell sample patient acute myeloid leukemia .</brief_summary>
	<brief_title>Drug Biomarkers Cell Samples From Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - To determine , vitro , cytotoxic activity novel CD33-targeting immunoconjugate agent cell sample patient acute myeloid leukemia ( AML ) . - To define characteristic AML cell respond resist agent . OUTLINE : Cell sample thaw used vitro study determine cytotoxic activity novel CD33-targeting immunoconjugate agent , include gemtuzumab ozogamicin , genotyping characterization flow cytometry-based assay and/or western blot , colony-forming cell assay .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute myeloid leukemia Cryopreserved sample available PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>adult acute myeloid leukemia 11q23 ( MLL ) abnormality</keyword>
	<keyword>adult acute myeloid leukemia del ( 5q )</keyword>
	<keyword>adult acute myeloid leukemia inv ( 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 15 ; 17 ) ( q22 ; q12 )</keyword>
	<keyword>adult acute myeloid leukemia ( 16 ; 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 8 ; 21 ) ( q22 ; q22 )</keyword>
	<keyword>childhood acute myeloid leukemia/other myeloid malignancy</keyword>
	<keyword>adult acute myeloid leukemia</keyword>
</DOC>